Scimago Journal & Country Rank
menu
| Title | Type | SJR | H index | Total Docs. (2020) | Total Docs. (3years) | Total Refs. (2020) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) |  Ref. / Doc. (2020) |
||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Pharmacological Reviews | journal | 8.176 Q1 | 254 | 26 | 65 | 10316 | 1412 | 65 | 22.15 | 396.77 |  |
| 2 | Drug Resistance Updates | journal | 4.010 Q1 | 132 | 27 | 52 | 6312 | 868 | 52 | 17.80 | 233.78 | |
| 3 | Advanced Drug Delivery Reviews | journal | 3.475 Q1 | 366 | 137 | 485 | 28532 | 7293 | 443 | 13.84 | 208.26 |  |
| 4 | Medicinal Research Reviews | journal | 2.868 Q1 | 150 | 81 | 162 | 16520 | 2023 | 160 | 12.29 | 203.95 | |
| 5 | Pharmacology and Therapeutics | journal | 3.461 Q1 | 233 | 151 | 450 | 30790 | 5501 | 450 | 11.71 | 203.91 | |
| 6 | Natural Product Reports | journal | 2.703 Q1 | 211 | 78 | 200 | 12856 | 2264 | 193 | 11.27 | 164.82 |  |
| 7 | Critical Reviews in Therapeutic Drug Carrier Systems | journal | 0.730 Q2 | 82 | 18 | 43 | 2951 | 201 | 43 | 4.93 | 163.94 | |
| 8 | Current Neuropharmacology | journal | 1.955 Q1 | 103 | 78 | 283 | 11625 | 2008 | 257 | 6.61 | 149.04 |  |
| 9 | Journal of Angiotherapy | journal | 2 | 2 | 5 | 274 | 0 | 5 | 0.00 | 137.00 |  | |
| 10 | Journal of Toxicology and Environmental Health - Part B: Critical Reviews | journal | 1.513 Q1 | 99 | 16 | 53 | 2147 | 345 | 49 | 5.33 | 134.19 | |
| 11 | Annual Review of Pharmacology and Toxicology | journal | 4.968 Q1 | 224 | 33 | 90 | 4408 | 1273 | 90 | 13.16 | 133.58 | |
| 12 | Drug Metabolism Reviews | journal | 1.023 Q1 | 108 | 27 | 78 | 3586 | 437 | 78 | 4.53 | 132.81 | |
| 13 | Current Medicinal Chemistry | journal | 0.934 Q1 | 202 | 382 | 1048 | 47291 | 4223 | 959 | 3.80 | 123.80 | |
| 14 | Interdisciplinary Toxicology | journal | 0.297 Q3 | 38 | 6 | 74 | 725 | 102 | 74 | 1.12 | 120.83 |  |
| 15 | Expert Opinion on Therapeutic Targets | journal | 1.964 Q1 | 106 | 103 | 291 | 12152 | 1629 | 257 | 5.41 | 117.98 | |
| 16 | Nano Today | journal | 5.586 Q1 | 175 | 128 | 153 | 15010 | 2993 | 153 | 19.62 | 117.27 | |
| 17 | Recent advances in inflammation & allergy drug discovery | journal | 37 | 13 | 47 | 1511 | 145 | 45 | 3.38 | 116.23 | | |
| 18 | Critical Reviews in Toxicology | journal | 1.092 Q1 | 129 | 51 | 122 | 5828 | 604 | 121 | 4.76 | 114.27 | |
| 19 | Profiles of Drug Substances, Excipients and Related Methodology | journal | 29 | 7 | 25 | 793 | 51 | 0 | 2.38 | 113.29 | | |
| 20 | Expert Opinion on Drug Metabolism and Toxicology | journal | 1.031 Q1 | 100 | 95 | 323 | 10735 | 1351 | 299 | 4.04 | 113.00 | |
| 21 | Cellular and Molecular Life Sciences | journal | 2.928 Q1 | 261 | 313 | 876 | 35261 | 7378 | 869 | 8.64 | 112.65 |  |
| 22 | Current Drug Targets | journal | 0.826 Q2 | 119 | 141 | 450 | 15650 | 1540 | 422 | 3.15 | 110.99 | |
| 23 | Expert Opinion on Emerging Drugs | journal | 0.975 Q2 | 54 | 41 | 78 | 4420 | 273 | 76 | 3.70 | 107.80 | |
| 24 | Advanced Therapeutics | journal | 0.125 Q4 | 39 | 78 | 155 | 8196 | 862 | 152 | 5.56 | 105.08 | |
| 25 | Handbook of Experimental Pharmacology | journal | 1.605 Q1 | 110 | 105 | 380 | 11026 | 1324 | 30 | 3.09 | 105.01 |  |
| 26 | Current Pharmaceutical Design | journal | 0.690 Q2 | 183 | 515 | 1637 | 53255 | 5006 | 1517 | 2.78 | 103.41 | |
| 27 | EPMA Journal | journal | 1.177 Q1 | 52 | 39 | 108 | 4020 | 677 | 106 | 6.61 | 103.08 | |
| 28 | Expert Opinion on Drug Discovery | journal | 1.316 Q1 | 84 | 123 | 320 | 12439 | 1736 | 266 | 4.77 | 101.13 | |
| 29 | Pharmacological Research | journal | 1.850 Q1 | 169 | 598 | 1048 | 58728 | 7342 | 971 | 6.90 | 98.21 | |
| 30 | Mini-Reviews in Medicinal Chemistry | journal | 0.603 Q2 | 107 | 149 | 359 | 14217 | 1277 | 339 | 3.65 | 95.42 | |
| 31 | Recent Patents on Anti-Cancer Drug Discovery | journal | 0.710 Q2 | 52 | 26 | 89 | 2460 | 300 | 85 | 3.84 | 94.62 | |
| 32 | Expert Review of Precision Medicine and Drug Development | journal | 0.387 Q3 | 16 | 43 | 115 | 4041 | 151 | 91 | 1.39 | 93.98 | |
| 33 | Journal of NeuroImmune Pharmacology | journal | 1.219 Q1 | 91 | 69 | 162 | 6473 | 611 | 149 | 3.23 | 93.81 | |
| 34 | Expert Opinion on Therapeutic Patents | journal | 1.121 Q1 | 88 | 71 | 253 | 6591 | 1462 | 244 | 6.40 | 92.83 | |
| 35 | CNS and Neurological Disorders - Drug Targets | journal | 0.923 Q2 | 96 | 65 | 287 | 5920 | 1076 | 265 | 3.94 | 91.08 | |
| 36 | Expert Opinion on Drug Delivery | journal | 1.084 Q1 | 133 | 133 | 320 | 12076 | 1939 | 291 | 6.14 | 90.80 | |
| 37 | Current Topics in Medicinal Chemistry | journal | 0.706 Q2 | 133 | 240 | 735 | 21755 | 2287 | 620 | 2.65 | 90.65 | |
| 38 | Expert Opinion on Orphan Drugs | journal | 0.237 Q3 | 27 | 49 | 228 | 4388 | 166 | 216 | 0.68 | 89.55 | |
| 39 | Expert Review of Vaccines | journal | 1.864 Q1 | 105 | 94 | 314 | 8262 | 1569 | 289 | 4.67 | 87.89 | |
| 40 | Neurotherapeutics | journal | 2.496 Q1 | 136 | 154 | 292 | 13488 | 2091 | 270 | 6.61 | 87.58 | |
| 41 | Journal of Controlled Release | journal | 2.119 Q1 | 313 | 540 | 1470 | 47197 | 13536 | 1392 | 9.01 | 87.40 | |
| 42 | Expert Review of Clinical Pharmacology | journal | 1.014 Q1 | 60 | 124 | 360 | 10783 | 1396 | 317 | 4.33 | 86.96 | |
| 43 | Neuropharmacology | journal | 1.760 Q1 | 191 | 417 | 1332 | 35128 | 6810 | 1306 | 4.79 | 84.24 | |
| 44 | Expert Opinion on Investigational Drugs | journal | 1.410 Q1 | 117 | 132 | 336 | 11059 | 1672 | 321 | 5.10 | 83.78 | |
| 45 | Current Pharmacology Reports | journal | 0.503 Q3 | 35 | 40 | 122 | 3327 | 221 | 120 | 1.60 | 83.18 | |
| 46 | Advanced healthcare materials | journal | 2.288 Q1 | 140 | 332 | 992 | 26712 | 9011 | 973 | 9.19 | 80.46 | |
| 47 | Progress in Neuro-Psychopharmacology and Biological Psychiatry | journal | 1.716 Q1 | 150 | 204 | 751 | 16345 | 3626 | 740 | 4.81 | 80.12 | |
| 48 | Current Cancer Drug Targets | journal | 0.972 Q1 | 103 | 75 | 237 | 5949 | 734 | 219 | 3.13 | 79.32 | |
| 49 | Particle and Fibre Toxicology | journal | 1.748 Q1 | 119 | 61 | 145 | 4821 | 1293 | 143 | 8.71 | 79.03 | |
| 50 | Current Gene Therapy | journal | 0.704 Q2 | 80 | 38 | 129 | 2994 | 406 | 113 | 3.25 | 78.79 | |
Powered by:
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®
Download data